HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells

Journal of Experimental Medicine

Volumn 196, Issue 11, 2002, Pages 1473-1481

  Heinzel, Amy S ^a   Grotzke, Jeff E ^a   Lines, Rebecca A ^a   Lewinsohn, Deborah A ^a   McNabb, Andria L ^b   Streblow, Daniel N ^a   Brand, Veronique M ^c   Grieser, Heather J ^d   Belisle, John T ^d   Lewinsohn, David M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b GLAXOSMITHKLINE   (United States)

^c CNRS   (France)

^d Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

CD8 positive T lymphocytes; HLA E; Human; Mycobacterium tuberculosis

Indexed keywords

CD1 ANTIGEN; CD8 ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; MYCOBACTERIUM ANTIGEN;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL INFECTION; CONTROLLED STUDY; HOST PATHOGEN INTERACTION; HOST RESISTANCE; HUMAN; HUMAN CELL; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGEN PRESENTATION; ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTIGENS, CD94; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INTERFERON TYPE II; LECTINS, C-TYPE; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, IMMUNOLOGIC;

EID: 0037011066     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020609     Document Type: Article

References (40)

1. World Health Organization. 2001. Global Tuberculosis Control. WHO Report 2001. Geneva, Switzerland, WHO/CDS/TB/2001.287. 181 pp.
2. Flynn, J.L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.
3. Raupach, B., and S.H. Kaufmann. 2001. Immune responses to intracellular bacteria. Curr. Opin. Immunol. 13:417-428.
4. Flynn, J.L., M.M. Goldstein, K.J. Triebold, B. Koller, and B.R Bloom. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA. 89:12013-12017.
5. Mogues, T., M. Goodrich, L. Ryan, R. LaCourse, and R. North. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193:271-280.
6. Behar, S.M., C.C. Dascher, M.J. Grusby, C.R. Wang, and M.B. Brenner. 1999. Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J. Exp. Med. 189:1973-1980.
7. Stenger, S., D.A. Hanson, R. Teitelbaum, P. Dewan, K.R. Niazi, C.J. Froelich, T. Ganz, S. Thoma-Uszynski, A. Melian, C. Bogdan, et al. 1998. An antimicrobial activity of cytolytic T cells mediated by granulysin. Science. 282:121-125.
8. + T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J. Exp. Med. 187:1633-1640.
9. + T lymphocytes: The relative contribution of classical versus nonclassical HLA restriction. J. Immunol. 165:925-930.
10. + T cells. Infect. Immun. 67:5223-5230.
11. Pathan, A.A., K.A. Wilkinson, RJ. Wilkinson, M. Latif, H. McShane, G. Pasvol, A.V. Hill, and A. Lalvani. 2000. High frequencies of circulating IFN-γ-secreting CD8 cytotoxic T cells specific for a novel MHC class I-restricted Mycobacterium tuberculosis epitope in M. tuberculosis-infected subjects without disease. Eur. J. Immunol. 30:2713-2721.
12. Mohagheghpour, N., D. Gammon, L.M. Kawamura, A. van Vollenhoven, C.J. Benike, and E.G. Engleman. 1998. CTL response to Mycobacterium tuberculosis: identification of an immnogenic epitope in the 19-kDa lipoprotein. J. Immunol. 161:2400-2406.
13. + T lymphocytes derived from Mycobacterium tuberculosis-infected cells: Definition of antigenic specificity. J. Immunol. 166:439-446.
14. Ulrichs, T., and S.A. Porcelli. 2000. CD1 proteins: Targets of T cell recognition in innate and adaptive immunity. Rev. Immunogenet. 2:416-432.
15. Pamer, E.G., C.R. Wang, L. Flaherty, K.F. Lindahl, and M.J. Bevan. 1992. H-2M3 presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes. Cell. 70:215-223.
16. Chun, T., N.V. Serbina, D. Nolt, B. Wang, N.M. Chiu, J.L. Flynn, and C.R. Wang. 2001. Induction of M3-restricted cytotoxic T lymphocyte responses by N-formylated peptides derived from Mycobacterium tuberculosis. J. Exp. Med. 193: 1213-1220.
17. + T cells in immunity to Salmonella infection and the involvement of MHC class Ib molecules. J. Immunol. 162:5398-5406.
18. Lo, W.F., A.S. Woods, A. DeCloux, R.J. Cotter, E.S. Metcalf, and M.J. Soloski. 2000. Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Nat. Med. 6:215-218.
19. Rolph, M.S., B. Raupach, H.H. Kobernick, H.L. Collins, B. Perarnau, F.A. Lemonnier, and S.H. Kaufmann. 2001. MHC class Ia-restricted T cells partially account for β2-microglobulin-dependent resistance to Mycobacterium tuberculosis. Eur. J. Immunol. 31:1944-1949.
20. Lee, N., D.R. Goodlett, A. Ishitani, H. Marquardt, and D.E. Geraghty. 1998. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160:4951-4960.
21. Storkus, W.J., M. Wei, P. Cresswell, and J.R. Dawson. 1996. Class I-like CD1A-C do not protect target cells from NK-mediated cytolysis. Cell. Immunol. 167:154-156.
22. Riddell, S.R., K.S. Watanabe, J.M. Goodrich, C.R. Li, M.E. Agha, and P.D. Greenberg. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science. 257:238-241.
23. Romani, N., S. Gruner, D. Brang, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P.O. Fritsch, R.M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83-93.
24. Lalvani, A., R. Brookes, S. Hambleton, W.J. Britton, A.V. Hill, and A.J. McMichael. 1997. Rapid effector function in CD8+ memory T cells. J. Exp. Med. 186:859-865.
25. Radolf, J.D., and M.V. Norgard. 1988. Pathogen specificity of Treponema pallidum subsp. pallidum integral membrane proteins identified by phase partitioning with Triton X-114. Infect. Immun. 56:1825-1828.
26. Smith, P.K., R.I. Krohn, G.T. Hennanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85.
27. Folch, J., M. Lees, and G.A. Sloane-Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497-509.
28. Neyrolles, O., K. Gould, M.P. Gares, S. Brett, R. Janssen, P. O'Gaora, J.L. Herrmann, M.C. Prevost, E. Perret, J.E. Thole, and D. Young. 2001. Lipoprotein access to MHC class I presentation during infection of murine macrophages with live mycobacteria. J. Immunol. 166:447-457.
29. Beatty, W.L., E.R. Rhoades, H.J. Ullrich, D. Chatterjee, J.E. Heuser, and D.G. Russell. 2000. Trafficking and release of mycobacterial lipids from infected macrophages. Traffic. 1:235-247.
30. Braud, V.M., D.S. Allan, C.A. O'Callaghan, K. Soderstrom, A. D'Andrea, G.S. Ogg, S. Lazetic, N.T. Young, J.I. Bell, J.H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 391:795-799.
31. Lee, N., M. Llano, M. Carretero, A. Ishitani, F. Navarro, M. Lopez-Botet, and D.E. Geraghty. 1998. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA. 95:5199-5204.
32. Martinozzi, S., R. Pacasova, H.J. Boulouis, M. Ulbrecht, E.H. Weiss, F. Sigaux, and M. Pla. 1999. Cutting edge: Requirement of class I signal sequence-derived peptides for HLA-E recognition by a mouse cytotoxic T cell clone.J. Immunol. 162:5662-5665.
33. Stevens, J., E. Joly, J. Trowsdale, and G.W. Butcher. 2001. Peptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by a recombinant random peptide approach. BMC Immunol. 2:5.
34. Pietra, G., C. Romagnani, M. Falco, M. Vitale, R. Castriconi, D. Pende, E. Millo, S. Anfossi, R. Biassoni, L. Moretta, and M.C. Mingari. 2001. The analysis of the natural killerlike activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR α/β-mediated recognition. Eur. J. Immunol. 31:3687-3693.
35. García, P., M. Llano, A.B. de Heredia, C.B. Willberg, E. Caparrós, P. Aparicio, V.M. Braud, and M. López-Botet. 2002. Human T cell receptor-mediated recognition of HLA-E. Eur. J. Immunol. 32:936-944.
36. Schumacher, T.N., M.T. Heemels, J.J. Neefjes, W.M. Kast, C.J. Melief, and H.L. Ploegh. 1990. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro. Cell. 62:563-567.
37. Tomasec, P., V.M. Braud, C. Rickards, M.B. Powell, B.P. McSharry, S. Gadola, V. Cerundolo, L.K. Borysiewicz, A.J. McMichael, and G.W. Wilkinson. 2000. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science. 287:1031.
38. Wilkinson, G.W., and A. Akrigg. 1992. Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector. Nucleic Acids Res. 20:2233-2239.
39. + T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway. J. Exp. Med. 194:1053-1068.
40. + T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA. 98:1160-1165.